<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Burkhart RA | Seppälä Lab</title><link>https://www.seppalalab.org/author/burkhart-ra/</link><atom:link href="https://www.seppalalab.org/author/burkhart-ra/index.xml" rel="self" type="application/rss+xml"/><description>Burkhart RA</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Wed, 01 Jan 2025 00:00:00 +0000</lastBuildDate><image><url>https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.png</url><title>Burkhart RA</title><link>https://www.seppalalab.org/author/burkhart-ra/</link></image><item><title>Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma</title><link>https://www.seppalalab.org/publication/smith-2025-therapeutic/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/smith-2025-therapeutic/</guid><description/></item><item><title>In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency</title><link>https://www.seppalalab.org/publication/kubota-2024-in/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/kubota-2024-in/</guid><description/></item><item><title>Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma</title><link>https://www.seppalalab.org/publication/nicolson-2024-patient-derived/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/nicolson-2024-patient-derived/</guid><description/></item><item><title>Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma</title><link>https://www.seppalalab.org/publication/guinn-2024-transfer/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/guinn-2024-transfer/</guid><description/></item><item><title>Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review</title><link>https://www.seppalalab.org/publication/seppala-2023-hereditary/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2023-hereditary/</guid><description/></item><item><title>Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response</title><link>https://www.seppalalab.org/publication/seppala-2022-precision/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2022-precision/</guid><description/></item><item><title>Solving for Chemotherapeutic Sensitivity: Adapting "Black Box" Methods to Study Patient-Derived Tumor Organoids</title><link>https://www.seppalalab.org/publication/seppala-2022-solving/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2022-solving/</guid><description/></item><item><title>Can Pancreatic Organoids Help in the Treatment of Pancreatic Cancer?</title><link>https://www.seppalalab.org/publication/seppala-2021-can/</link><pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2021-can/</guid><description/></item><item><title>Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer</title><link>https://www.seppalalab.org/publication/seppala-2020-patient-derived/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/publication/seppala-2020-patient-derived/</guid><description/></item></channel></rss>